Yes, labetalol is contraindicated in asthma. The FDA-approved prescribing information lists bronchial asthma and obstructive airway disease as explicit contraindications for both the oral tablet and injectable forms of the drug. This is not a soft warning or a relative precaution. It is a formal contraindication, meaning the drug should not be used in people with asthma.
Why Labetalol Triggers Airway Problems
Labetalol is a blood pressure medication that blocks both alpha and beta receptors. The alpha-to-beta blockade ratio is roughly 1:3 when taken orally and 1:7 when given intravenously, meaning beta blockade dominates. That beta blockade is the problem for people with asthma.
Your airways have beta-2 receptors that, when activated, keep the bronchial muscles relaxed and open. Labetalol blocks those receptors, which causes the airway muscles to constrict. This is the same mechanism that rescue inhalers work through in reverse: albuterol (salbutamol) activates beta-2 receptors to open airways, while labetalol blocks them. In clinical testing, labetalol significantly reduced the effectiveness of inhaled salbutamol on lung function measures, meaning it can undermine the very medications used to treat an asthma attack.
What the Clinical Data Shows
A large study examining over 239,000 deliveries complicated by preeclampsia found that when IV labetalol was given to patients with asthma, the rate of status asthmaticus (a severe, life-threatening asthma attack) was 6.5 per 1,000 hospitalizations, compared to 1.7 per 1,000 when other blood pressure medications were used. That is nearly a fourfold increase in severe asthma events. Notably, the study also found that labetalol was actually used more often in patients who had an asthma diagnosis (18.5% vs. 16.7%), suggesting the contraindication is sometimes overlooked in clinical practice.
The Pregnancy Complication
This question comes up frequently in the context of pregnancy because labetalol is one of the most commonly prescribed drugs for preeclampsia and chronic hypertension during pregnancy. The American College of Obstetrics and Gynecology lists labetalol as a first-choice drug for hypertension in pregnancy but explicitly states that both oral and IV forms should be avoided in pregnant patients with preexisting asthma because of the risk of precipitating bronchospasm. The American Heart Association similarly lists preexisting asthma as a contraindication to labetalol use for hypertensive emergencies in pregnancy.
If you are pregnant, have high blood pressure, and also have asthma, your provider should choose a different medication. The contraindication applies regardless of how well controlled your asthma is.
Other Lung Conditions Carry the Same Risk
The FDA labeling extends the warning beyond asthma. It states that beta-blockers, even those considered more heart-selective than labetalol, should not be used in patients with a history of obstructive airway disease. For nonallergic bronchospastic conditions like chronic bronchitis and emphysema, the injectable form of labetalol has not been studied, and the labeling says it should not be used in these patients either. If you have any condition that narrows your airways or makes breathing difficult, labetalol poses the same fundamental risk.
Blood Pressure Alternatives for People With Asthma
Several classes of blood pressure medication are considered safer for people with reactive airway disease. Thiazide diuretics are generally recommended as the initial choice, since they lower blood pressure through a completely different mechanism (reducing fluid volume) and have no effect on airway receptors. Calcium channel blockers are a strong second option. Calcium plays a key role in muscle contraction, including in the airways, and these drugs tend to relax rather than constrict bronchial tissue.
For patients who do not respond adequately to those two classes, angiotensin receptor blockers are another option. Some newer, highly selective beta-1 blockers like nebivolol and celiprolol have properties that make them less likely to affect the airways, though they still require caution. The important point is that effective alternatives exist. There is no clinical scenario where labetalol is the only option for blood pressure control.
If you are currently taking labetalol and have asthma, do not stop the medication abruptly, as sudden withdrawal of any beta-blocker can cause rebound effects including dangerous spikes in heart rate and blood pressure. A transition to a safer medication should be done gradually with your prescriber’s guidance.